Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Yesterday, my friend who lives in the Bay Area told me that I should be asking people about their peptide “stack,” which is where someone takes multiple peptides for presumably greater health benefit.

So, uh … are you taking peptides? What’s your stack? Or is this just a Bay Area bonanza?

A win for peptide proponents An advisory panel to the Food and Drug Administration recommended yesterday that compounding pharmacies be allowed to manufacture four peptides, the little-researched but highly popular drugs that people are taking to improve their health. It’s unusual for the FDA to go against the recommendations of the Pharmacy Compounding Advisory Committee, but the vote outcome reflected the tensions between FDA staff and the panel. Critics have said the panel was “stacked” by Kennedy — a self-declared peptides user — with people who stand to benefit from broader peptide access.

The panel will vote Friday on additional compounds. Who voted to approve these? STAT’s Sarah Todd and Lizzy Lawrence have the readout.

I regret to inform you … … that there is another cyclospora outbreak. Federal health officials are investigating a new outbreak of the diarrhea-causing parasite. We don’t know where or which products are linked, but they did announce 72 new cases.

The United States is already facing the largest cyclospora outbreak in recorded history. On Tuesday, the CDC announced that it had received reports of 4,173 confirmed cases, with thousands of additional cases still to be processed. Officials said they were focused on lettuce from Taylor Farms as the source of this separate, multistate outbreak.

The company has recalled iceberg lettuce grown in central Mexico. Wash your fruit and veggies, everyone. Read more.

Senate health panel delays vote on CDC director candidate The search for the next CDC director drags on after a Senate committee postponed a vote on Erica Schwartz to run the Centers for Disease Control and Prevention until next week. Health committee chair Sen. Bill Cassidy (R-La.) said he had enough votes to advance former deputy surgeon general Schwartz out of the committee, where the GOP holds a one-vote advantage.

However, the vote on Schwartz was pushed back because too few senators showed up. We’re now at 331 days since the agency had a full-time chief after health secretary Robert F. Kennedy Jr.

sacked CDC Director Susan Monarez last summer. STAT’s Chelsea Cirruzzo has the scoop. A new golden age of science?

Science advocates have spent 18 months accusing the Trump administration of what they see as shredding the existing social contract between academic researchers and the federal government, a relationship that made the United States the world’s most powerful engine of discovery. Now, the administration has a proposal to update that relationship. Trump science adviser Michael Kratsios, who is not a scientist, has published a report that he hopes will usher in “A New Golden Age.” It calls for new grant funding mechanisms, embraces an ethos of funding people rather than projects, and pushes an image of innovation that centers industry over academia.